Ambient carbon dioxide concentration correlates with SARS-CoV-2 aerostability and infection risk Nature - 25 Apr 2024 Ambient carbon dioxide concentration correlates with SARS-CoV-2 aerostability and infection risk ... More
Statement on the antigen composition of COVID-19 vaccines World Health Organization (WHO) - 26 Apr 2024 Statement on the antigen composition of COVID-19 vaccines ... More
New tARC-seq method enhances precision in tracking SARS-CoV-2 mutations News-Medical.Net - 24 Apr 2024 New tARC-seq method enhances precision in tracking SARS-CoV-2 mutations ... More
SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance — Respiratory Virus Transmission Network ... 코로나바이러스 - 25 Apr 2024 SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance — Respiratory Virus Transmission Network ... ... More
Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants ... Nature - 27 Apr 2024 Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants ... ... More
Laboratory biosafety guidance related to SARS-CoV-2 (COVID-19): Interim guidance, 11 March 2024 World Health Organization (WHO) - 11 Mar 2024 Laboratory biosafety guidance related to SARS-CoV-2 (COVID-19): Interim guidance, 11 March 2024 ... More
Targeted accurate RNA consensus sequencing (tARC-seq) reveals mechanisms of replication error affecting SARS ... Nature - 22 Apr 2024 Targeted accurate RNA consensus sequencing (tARC-seq) reveals mechanisms of replication error affecting SARS ... ... More
Age-specific nasal epithelial responses to SARS-CoV-2 infection Nature - 15 Apr 2024 Age-specific nasal epithelial responses to SARS-CoV-2 infection ... More
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination Nature - 14 Mar 2024 Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination ... More
Research progress of post-acute sequelae after SARS-CoV-2 infection | Cell Death & Disease Nature - 11 Apr 2024 Research progress of post-acute sequelae after SARS-CoV-2 infection | Cell Death & Disease ... More
Prevalence of persistent SARS-CoV-2 in a large community surveillance study Nature - 21 Feb 2024 Prevalence of persistent SARS-CoV-2 in a large community surveillance study ... More
Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly Nature - 20 Jan 2024 Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly ... More
SARS-CoV-2 biology and host interactions Nature - 15 Jan 2024 SARS-CoV-2 biology and host interactions ... More
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge Nature - 20 Feb 2024 Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge ... More
Using big sequencing data to identify chronic SARS-Coronavirus-2 infections Nature - 20 Jan 2024 Using big sequencing data to identify chronic SARS-Coronavirus-2 infections ... More
SARS-CoV-2 nsp3 and nsp4 are minimal constituents of a pore spanning replication organelle Nature - 30 Nov 2023 SARS-CoV-2 nsp3 and nsp4 are minimal constituents of a pore spanning replication organelle ... More
Prevalence, outcomes and associated factors of SARS-CoV-2 infection in psoriasis patients of Southwest China: a ... Nature - 15 Mar 2024 Prevalence, outcomes and associated factors of SARS-CoV-2 infection in psoriasis patients of Southwest China: a ... ... More
A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses Nature - 25 Sep 2023 A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses ... More
SARS-CoV-2 rapidly evolves lineage-specific phenotypic differences when passaged repeatedly in immune-naïve ... Nature - 16 Feb 2024 SARS-CoV-2 rapidly evolves lineage-specific phenotypic differences when passaged repeatedly in immune-naïve ... ... More